Literature DB >> 1929281

Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.

R Leclercq1, P Courvalin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1929281      PMCID： PMC245157          DOI： 10.1128/AAC.35.7.1273

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  28 in total

1.  Novel mechanism for plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidermidis.

Authors:  B C Lampson; W von David; J T Parisi
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

2.  Plasmid-mediated high-level resistance to erythromycin in Escherichia coli.

Authors:  A Andremont; G Gerbaud; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

3.  Evolution and epidemiology of MLS resistance.

Authors:  J Duval
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

4.  Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli.

Authors:  H Ounissi; P Courvalin
Journal:  Gene       Date:  1985       Impact factor: 3.688

5.  Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II.

Authors:  M Arthur; D Autissier; P Courvalin
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

6.  Contribution of two different mechanisms to erythromycin resistance in Escherichia coli.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

7.  Macrolide-lincosamide-streptogramin resistance patterns in Clostridium perfringens from animals.

Authors:  G N Dutta; L A Devriese
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

8.  Reduction of the aerobic Gram negative bacterial flora of the gastro-intestinal tract and prevention of traveller's diarrhea using oral erythromycin.

Authors:  A Andremont; C Tancrede
Journal:  Ann Microbiol (Paris)       Date:  1981 Nov-Dec

9.  Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin.

Authors:  M Arthur; A Andremont; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance.

Authors:  P Barthélémy; D Autissier; G Gerbaud; P Courvalin
Journal:  J Antibiot (Tokyo)       Date:  1984-12       Impact factor: 2.649
View more
  56 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Diminished killing of pneumococci by pristinamycin demonstrated by time-kill studies.

Authors:  L Schlegel; G Sissia; A Frémaux; P Geslin
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.

Authors:  L Zarantonelli; G Borthagaray; E H Lee; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

4.  The macrolide-lincosamide-streptogramin B resistance determinant from Clostridium difficile 630 contains two erm(B) genes.

Authors:  K A Farrow; D Lyras; J I Rood
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

5.  Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, China.

Authors:  Zhao Tiemei; Fang Xiangqun; Liu Youning
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 6.  Review of macrolides and ketolides: focus on respiratory tract infections.

Authors:  G G Zhanel; M Dueck; D J Hoban; L M Vercaigne; J M Embil; A S Gin; J A Karlowsky
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  Characterization of ermA in macrolide-susceptible strains of methicillin-resistant Staphylococcus aureus.

Authors:  Henry Wong; Lisa Louie; Christine Watt; Eric Sy; Reggie Y C Lo; Michael R Mulvey; Andrew E Simor
Journal:  Antimicrob Agents Chemother       Date:  2009-06-01       Impact factor: 5.191

8.  Resistance Genes Underlying the LSA Phenotype of Staphylococcal Isolates from France.

Authors:  Sophie Tessé; François Trueba; Nicolas Berthet; Chloé Hot; Olivier Chesneau
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

9.  Characterization and prevalence of MefA, MefE, and the associated msr(D) gene in Streptococcus pneumoniae clinical isolates.

Authors:  Melissa M Daly; Stella Doktor; Robert Flamm; Dee Shortridge
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

Authors:  L Wondrack; M Massa; B V Yang; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.